Chargement de la fiche…
Chargement de la fiche…
Hospitalo-universitaire
Intérêt du monitoring des biomédicaments pour le rhumatologue par Hubert MAROTTESemaine Rhumatologie AixPhoto : Ian42, CC BY-SA 3.0, Wikimedia Commons
Dans les médias
Vous êtes Pr Hubert Marotte ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Pr Hubert Marotte est rhumatologue à Saint-Priest-en-Jarez (42277). Il consulte à HOPITAL NORD - CHU42, Avenue ALBERT RAIMOND, 42277 Saint-Priest-en-Jarez.
Consulter
HOPITAL NORD - CHU42
Avenue ALBERT RAIMOND, 42277 Saint-Priest-en-Jarez
Pr Hubert Marotte, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
Les plus citées
2023Journal of comparative effectiveness research26 citations
Navigating adalimumab biosimilars: an expert opinion
2023Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver22 citations
Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study
2024Joint bone spine20 citations
2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Pr Hubert Marotte consulte à HOPITAL NORD - CHU42, Avenue ALBERT RAIMOND, 42277 Saint-Priest-en-Jarez. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 04 77 82 80 02 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Rhumatologues à Saint-Priest-en-Jarez →Rhumatologues en Loire (42) →
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Saint-Priest-en-Jarez, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Histological validation of barium-filled vascular channels detected by high-resolution peripheral quantitative computed tomography in rheumatoid arthritis: an exploratory cadaveric study
2026Joint bone spinePubMed
Serum biomarkers fail to predict response to adalimumab in axial spondyloarthritis: Results from discovery and validation cohorts
2026Clinical and experimental medicinePubMed
No serological association between Porphyromonas gingivalis or Prevotella intermedia and early spondyloarthritis: analysis from the DESIR cohort
2026RMD openPubMed
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
2026Annals of the rheumatic diseasesPubMed
Evaluation of pregnancy outcomes in patients with spondyloarthritis compared to the general population: results from a French national prospective and matched study
2025RMD openPubMed
When generative artificial intelligence answers to Google Trends about spondyloarthritis: what does a French expert panel think about it?
2024Joint bone spinePubMed
Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshop
2024RMD openPubMed
NSAID exposure delays time-to-pregnancy in patients with spondyloarthritis: an analysis of the GR2 prospective cohort
2024BMJ openPubMed
Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol
2024Joint bone spinePubMed
Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative
2023Joint bone spinePubMed
Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort
2023Frontiers in physiologyPubMed
Novel insights into the anatomy and histopathology of the sacroiliac joint and correlations with imaging signs of sacroiliitis in case of axial spondyloarthritis
2026Expert opinion on biological therapyPubMed
Shared challenges in the management of difficult-to-treat chronic inflammatory diseases: expert perspectives
2026Joint bone spinePubMed
Early upper and lower limbs bone microarchitecture alterations evaluated by HR-PQCT after stroke with hemiplegia
2026Calcified tissue internationalPubMed
Ano1 Antisense Therapy Improves Enamel Properties in Molars but not Amelogenesis in a Murine Model of Cystic Fibrosis
2026Audiology researchPubMed
Manual Insertion of Cochlear Implant Electrodes Versus Robot-Assisted Insertion and Analysis by Micro-CT: A Temporal Bone Study
2026International journal of infectious diseases : IJID : official publication of the International Society for Infectious DiseasesPubMed
Accuracy of VIDAS(Ⓡ) TB-IGRA in TB patients and individuals with different thresholds of exposure
2025Journal of vascular and interventional radiology : JVIRPubMed
Combination Therapy Using Embolization, Gelified Alcohol Sclerotherapy, and Vertebroplasty to Treat Aggressive Vertebral Hemangioma: Technique and Initial Results
2023Experimental gerontologyPubMed
Dietary supplementation with nacre reduces cortical bone loss in aged female mice
2023Joint bone spinePubMed
Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves
2023Frontiers in medicinePubMed
CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases
2026Rheumatology (Oxford, England)PubMed
DNA hypo-methylation of the TNFA gene predicts response to MTX in RA but not in PsA
2025The Lancet. RheumatologyPubMed
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2025Therapeutic drug monitoringPubMed
Misleading Renal Function Evaluation Leading to Severe Methotrexate-Induced Toxicity
2025Fundamental & clinical pharmacologyPubMed
Long-term evaluation of rheumatoid arthritis activity with erythrocyte methotrexate-polyglutamate 3
2024Rheumatology and therapyPubMed
Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary
2024Rheumatology (Oxford, England)PubMed
Proteomics analyses of human plasma reveal triosephosphate isomerase as a potential blood marker of methotrexate resistance in rheumatoid arthritis
2023Rheumatology (Oxford, England)PubMed
Similar effect of co-administration of methotrexate and folic acid for the treatment of arthritis compared to separate administration
2026Joint bone spinePubMed
Serum biomarkers fail to predict response to adalimumab in axial spondyloarthritis: Results from discovery and validation cohorts
2026Rheumatology and therapyPubMed
Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study
2025Advances in therapyPubMed
Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)
2025Rheumatology (Oxford, England)PubMed
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
2024BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapyPubMed
Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER Study
2023Journal of comparative effectiveness researchPubMed
Navigating adalimumab biosimilars: an expert opinion
2026The Lancet. RheumatologyPubMed
Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial
2025BMJ openPubMed
CADOR (Capsaicin in neuropathic-like pain in digital osteoarthritis) study protocol: a multicentre randomised parallel-group trial
2026 · Article
Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched study
2026 · Article
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren’s syndrome
2026 · Article
Shared challenges in the management of difficult-to-treat chronic inflammatory diseases: expert perspectives
2026 · Article
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
2026 · Article
Evaluation of pregnancy outcomes in patients with spondyloarthritis compared to the general population: results from a French national prospective and matched study
2026 · Article
Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study
2025 · Article
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposure
2025 · Article
Baseline characteristics of the TRANSLATE2 cohort: a prospective study on rheumatoid arthritis-associated interstitial lung disease
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.
2023 · doctorant : Elisa Dalix
Effet des contraintes mécaniques sur le développement de l'arthrite
2021 · doctorant : Robin Caire
Implication de YAP/TAZ dans l'inflammation
2016 · doctorant : Guillaume Courbon
Etudes cinétiques de la perte osseuse au cours de l'inflammation articulaire chronique
2015 · doctorant : Melanie Gaujous
Etude de marqueurs biologiques prédictifs de la perte de réponse aux anti-TNFa
— · doctorant : Khadidja Chemini
Caractérisation de la Pneumopathie Interstitielle Associée à la Polyarthrite Rhumatoïde dans le Modèle de Rat d'Arthrite Induite par Adjuvant
— · doctorant : Franck Zekre
Modèle d'arthrite inflammatoire après infection à Porphyromonas gingivalis chez le rat. Essai d'une vaccination thérapeutique. Etude d'immunisation et des conséquences sur la survenue d'arthrite inflammatoire